ES332215A1 - Un metodo para elaborar tabletas farmaceuticas de libera- cion lenta. - Google Patents
Un metodo para elaborar tabletas farmaceuticas de libera- cion lenta.Info
- Publication number
- ES332215A1 ES332215A1 ES332215A ES332215A ES332215A1 ES 332215 A1 ES332215 A1 ES 332215A1 ES 332215 A ES332215 A ES 332215A ES 332215 A ES332215 A ES 332215A ES 332215 A1 ES332215 A1 ES 332215A1
- Authority
- ES
- Spain
- Prior art keywords
- tablets
- substance
- release delay
- suspended
- heating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 3
- 239000011248 coating agent Substances 0.000 abstract 3
- 238000000576 coating method Methods 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 3
- 238000010438 heat treatment Methods 0.000 abstract 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 abstract 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 229940125716 antipyretic agent Drugs 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000004203 carnauba wax Substances 0.000 abstract 1
- 235000013869 carnauba wax Nutrition 0.000 abstract 1
- 229960000541 cetyl alcohol Drugs 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 229940030606 diuretics Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000012170 montan wax Substances 0.000 abstract 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 abstract 1
- 239000012188 paraffin wax Substances 0.000 abstract 1
- 230000001003 psychopharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000001993 wax Substances 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/003—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic followed by coating of the granules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/006—Coating of the granules without description of the process or the device by which the granules are obtained
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK522265 | 1965-10-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES332215A1 true ES332215A1 (es) | 1968-05-01 |
Family
ID=8140572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES332215A Expired ES332215A1 (es) | 1965-10-12 | 1966-10-13 | Un metodo para elaborar tabletas farmaceuticas de libera- cion lenta. |
Country Status (11)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH574245A5 (enrdf_load_html_response) * | 1971-06-04 | 1976-04-15 | Boehringer Mannheim Gmbh | |
| JPS5031022A (enrdf_load_html_response) * | 1973-05-29 | 1975-03-27 | ||
| FR2383659A1 (fr) * | 1977-03-16 | 1978-10-13 | Berri Balzac | Procede de preparation de comprimes contenant des substances labiles en microdispersion |
| US4673527A (en) * | 1985-05-20 | 1987-06-16 | Autotrol Corporation | Tablet granulation |
| JPH03232814A (ja) * | 1990-02-08 | 1991-10-16 | Shin Etsu Chem Co Ltd | 徐放性錠剤の製造方法 |
| DE69216642T2 (de) * | 1992-01-13 | 1997-05-07 | Pfizer | Verfahren zur herstellung von tabletten mit hoher festigkeit |
| DE19729487A1 (de) * | 1997-07-10 | 1999-01-14 | Dresden Arzneimittel | Verfahren zur Herstellung von Wirkstoff-Zubereitungen mit kontrollierter Freisetzung aus einer Matrix |
| CN103948556A (zh) * | 2014-04-08 | 2014-07-30 | 闻晓光 | 一种新型控释片 |
-
1966
- 1966-09-24 DE DE19661617593 patent/DE1617593A1/de active Pending
- 1966-10-06 GB GB4463266A patent/GB1137156A/en not_active Expired
- 1966-10-07 FI FI264266A patent/FI48245B/fi active
- 1966-10-11 SE SE6613760A patent/SE337281C/xx unknown
- 1966-10-11 NO NO16510066A patent/NO126201B/no unknown
- 1966-10-11 FR FR1602625D patent/FR1602625A/fr not_active Expired
- 1966-10-12 BR BR18360666A patent/BR6683606D0/pt unknown
- 1966-10-12 CA CA972,775A patent/CA983393A/en not_active Expired
- 1966-10-12 BE BE688121A patent/BE688121A/xx unknown
- 1966-10-12 NL NL6614357A patent/NL6614357A/xx unknown
- 1966-10-13 ES ES332215A patent/ES332215A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FI48245B (enrdf_load_html_response) | 1974-04-30 |
| GB1137156A (en) | 1968-12-18 |
| FR1602625A (en) | 1971-01-04 |
| BE688121A (enrdf_load_html_response) | 1967-04-12 |
| NO126201B (enrdf_load_html_response) | 1973-01-08 |
| CA983393A (en) | 1976-02-10 |
| NL6614357A (enrdf_load_html_response) | 1967-04-13 |
| SE337281B (enrdf_load_html_response) | 1971-08-02 |
| SE337281C (enrdf_load_html_response) | 1975-10-20 |
| BR6683606D0 (pt) | 1973-11-13 |
| DE1617593A1 (de) | 1971-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES423856A1 (es) | Procedimiento para la elaboracion de medicamentos con ce- sion retardada de la sustancia activa en el instestino. | |
| CA1165691A (en) | Retarded release pharmaceutical composition and process | |
| US3279998A (en) | Method of preparing sustained release tablets | |
| US3670065A (en) | Process for producing dosage units of a type resembling tablets | |
| US4132753A (en) | Process for preparing oral sustained release granules | |
| US3119742A (en) | Method of preparing sustained release pharmaceutical pellets and product thereof | |
| JP4308339B2 (ja) | 固体または半固体の、少なくとも２相の活性成分含有製剤およびその製造方法 | |
| GB906422A (en) | Improvements in and relating to prolonged acting pharmaceutical preparations | |
| ES332215A1 (es) | Un metodo para elaborar tabletas farmaceuticas de libera- cion lenta. | |
| JPS56140915A (en) | Pharmaceutical preparation for solid drug | |
| CA2341646C (en) | Method for producing solid dosing forms | |
| KR920000309A (ko) | 압출에 의한 활성 성분 과립 제조 방법 및 이로써 얻어진 과립 | |
| DE2961284D1 (en) | Tetrahydropyridinyl indole derivatives and their salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them | |
| ATE66144T1 (de) | Herstellungsverfahren fuer arzneimittel mit verzoegerter wirkstoffabgabe. | |
| CA997677A (en) | Layered bolus for animal husbandry providing for immediate and sustained release of medicament | |
| WO2005000237B1 (en) | Granules containing biologically active substances | |
| GB772315A (en) | Method of preparing a compact and air-tight tablet | |
| GB1179938A (en) | Medicinal Sustained-Release Tablets. | |
| BE762716A (fr) | Procede de preparation de doses unitaires a l'etat solide pour l'administration de medicaments et produits obtenus | |
| US2895881A (en) | Quinidine gluconate sustained medication tablet | |
| GB1084864A (en) | Medicated lozenges | |
| ES403326A1 (es) | Procedimiento para la granulacion de masas para tabletas enforma de polvo. | |
| NL160556C (nl) | Werkwijze voor het bereiden van een veterinair farmaceu- tisch preparaat met bactericide werking op basis van een chinoxaline-1,4-dioxyde-ester, het gevormde preparaat, diervoeder en diervoedertoevoeging alsmede werkwijze voor het bereiden van een chinoxaline-1,4-dioxyde-ester. | |
| IL26306A (en) | Pharmaceutical preparation containing 1,3-dihydro-7-nitro-5-phenyl-2h-1,4-benzodiazepin-2-one and process for the manufacture thereof | |
| GB1064582A (en) | Lipid-containing sustained release pharmaceutical compositions |